UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
beta-alanine - analogs & derivatives (1913) 1913
science & technology (1903) 1903
life sciences & biomedicine (1813) 1813
humans (1776) 1776
dabigatran (1054) 1054
male (1000) 1000
animals (928) 928
female (719) 719
beta-alanine - pharmacology (696) 696
beta-alanine - therapeutic use (645) 645
biological and medical sciences (637) 637
benzimidazoles - therapeutic use (609) 609
beta-alanine - administration & dosage (523) 523
benzimidazoles - adverse effects (517) 517
beta-alanine - adverse effects (502) 502
anticoagulants - therapeutic use (437) 437
rivaroxaban (433) 433
beta-alanine - metabolism (415) 415
atrial fibrillation - drug therapy (396) 396
rats (396) 396
aged (393) 393
benzimidazoles - administration & dosage (379) 379
cardiovascular system & cardiology (375) 375
medical sciences (351) 351
stroke - prevention & control (341) 341
anticoagulants (338) 338
fundamental and applied biological sciences. psychology (331) 331
anticoagulants - adverse effects (326) 326
administration, oral (317) 317
biochemistry & molecular biology (311) 311
beta-alanine - chemistry (300) 300
atrial fibrillation (293) 293
anticoagulants - administration & dosage (291) 291
thiophenes - therapeutic use (283) 283
morpholines - therapeutic use (279) 279
middle aged (274) 274
abridged index medicus (273) 273
atrial fibrillation - complications (260) 260
hemorrhage - chemically induced (246) 246
kinetics (246) 246
warfarin - therapeutic use (243) 243
cardiac & cardiovascular systems (237) 237
pharmacology & pharmacy (236) 236
antithrombins - adverse effects (220) 220
beta-alanine (218) 218
pyrazoles - therapeutic use (216) 216
pyridones - therapeutic use (216) 216
neurosciences & neurology (211) 211
adult (210) 210
mice (209) 209
antithrombins - therapeutic use (205) 205
warfarin (201) 201
general & internal medicine (198) 198
treatment outcome (198) 198
peripheral vascular disease (197) 197
aged, 80 and over (187) 187
medicine, general & internal (183) 183
amino acids (182) 182
pharmacology. drug treatments (182) 182
chemistry (179) 179
stroke - etiology (178) 178
dose-response relationship, drug (177) 177
beta-alanine - pharmacokinetics (175) 175
stroke (168) 168
hematology (165) 165
warfarin - adverse effects (164) 164
neurosciences (162) 162
risk factors (160) 160
physical sciences (159) 159
morpholines - adverse effects (152) 152
thiophenes - adverse effects (152) 152
antithrombins - administration & dosage (149) 149
morpholines - administration & dosage (149) 149
thiophenes - administration & dosage (149) 149
dietary supplements (147) 147
time factors (144) 144
β-alanine (144) 144
analysis (137) 137
thromboembolism - prevention & control (126) 126
taurine - pharmacology (117) 117
warfarin - administration & dosage (115) 115
research (114) 114
in vitro techniques (113) 113
thrombin (113) 113
pyrazoles - administration & dosage (112) 112
alanine (111) 111
benzimidazoles - pharmacology (111) 111
pyridones - administration & dosage (110) 110
drug therapy (109) 109
beta-alanine - blood (108) 108
cells, cultured (106) 106
physiology (105) 105
taurine - metabolism (105) 105
pyrazoles - adverse effects (103) 103
pyridones - adverse effects (101) 101
amino acids - metabolism (98) 98
alanine - analogs & derivatives (96) 96
carnosine (94) 94
apixaban (92) 92
taurine (92) 92
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2859) 2859
Japanese (107) 107
German (54) 54
Russian (41) 41
Spanish (38) 38
French (33) 33
Chinese (17) 17
Portuguese (13) 13
Italian (9) 9
Danish (5) 5
Finnish (5) 5
Swedish (5) 5
Hungarian (4) 4
Polish (4) 4
Czech (3) 3
Norwegian (2) 2
Dutch (1) 1
Korean (1) 1
Persian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 8, pp. 709 - 718
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 6, pp. 511 - 520
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 02/2013, Volume 109, Issue 4, pp. 596 - 605
Journal Article
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2011, Volume 154, Issue 1, pp. 1 - 11
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Prevention and actions | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Myocardial Infarction - chemically induced | Markov Chains | Anticoagulants - administration & dosage | Humans | Anticoagulants - economics | Warfarin - adverse effects | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Warfarin - administration & dosage | Fibrinolytic Agents - adverse effects | Ischemic Attack, Transient - prevention & control | Benzimidazoles - administration & dosage | beta-Alanine - economics | Sensitivity and Specificity | Aged, 80 and over | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Quality-Adjusted Life Years | Stroke - prevention & control | beta-Alanine - adverse effects | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Fibrinolytic Agents - economics | Cost-Benefit Analysis | Intracranial Hemorrhages - chemically induced | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Stroke (Disease) | Prevention | Complications and side effects | Warfarin | Atrial fibrillation | Dosage and administration | Research | Drug therapy | Risk factors | Cardiac arrhythmia | Anticoagulants | Pharmacology | Internal medicine | Index Medicus | Abridged Index Medicus
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 04/2011, Volume 105, Issue 4, pp. 721 - 729
Dabigatran etexilate | Oral anticoagulant | Total hip arthroplasty | Venous thromboembolism | Prophylaxis | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Cardiology. Vascular system | Hematologic and hematopoietic diseases | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Blood and lymphatic vessels | Platelet diseases and coagulopathies | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Dabigatran | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Benzimidazoles - administration & dosage | Hemorrhage - etiology | Injections, Subcutaneous | Female | Venous Thrombosis - prevention & control | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Postoperative Complications | beta-Alanine - adverse effects | Double-Blind Method | Administration, Oral | Venous Thrombosis - mortality | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Venous Thromboembolism - etiology | Antithrombins - adverse effects | Survival Analysis | Arthroplasty, Replacement, Hip - mortality | Aged | Benzimidazoles | Venous Thrombosis | Oral | Hemorrhage | Antithrombins | Venous Thromboembolism | administration & dosage | Surgery | beta-Alanine | Administration | Anticoagulants | Subcutaneous | Enoxaparin | Arthroplasty | Replacement | prevention & control | Kirurgi | Hip | etiology | Injections | analogs & derivatives | adverse effects | mortality
Journal Article
Stroke (1970), ISSN 0039-2499, 06/2013, Volume 44, Issue 6, pp. 1676 - 1681
Intracranial hemorrhage | Stroke | Anticoagulation | Markov model | Cost-effectiveness | Atrial fibrillation | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Neurology | Cardiac dysrhythmias | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Thiophenes - therapeutic use | Markov Chains | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | United States | Humans | Anticoagulants - economics | Thiophenes - administration & dosage | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Warfarin - administration & dosage | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - economics | Stroke - epidemiology | Thiophenes - economics | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Stroke - prevention & control | Administration, Oral | Morpholines - administration & dosage | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Models, Statistical | Pyrazoles - economics | Pyrazoles - administration & dosage | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use | Cohort Studies | Index Medicus
Journal Article